Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
fertility, other
Remarks:
QSAR
Type of information:
(Q)SAR
Adequacy of study:
weight of evidence
Study period:
2019
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
results derived from a valid (Q)SAR model and falling into its applicability domain, with limited documentation / justification
Justification for type of information:
The aim of this study is to assess the hazardous potential of the substance 10-(2, 5-Dihydroxyphenyl)-10H-9-oxa-10-phosphaphenanthrene-10-oxide (DOPO-HQ) with respect to repeated dose toxicity and related reproductive and developmental toxicity effects. The assessment will include expert analysis on the reactivity and possible transformations of the target chemical as well as in silico predictions.

Data source

Reference
Reference Type:
other: QSAR analysis
Title:
Unnamed
Year:
2019
Report date:
2019

Materials and methods

Principles of method if other than guideline:
QSAR
GLP compliance:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
9-(2,5-dihydroxyphenyl)-8-oxa-9λ⁵-phosphatricyclo[8.4.0.0²,⁷]tetradeca-1(14),2,4,6,10,12-hexaen-9-one
EC Number:
619-409-6
Cas Number:
99208-50-1
Molecular formula:
C18H13O4P
IUPAC Name:
9-(2,5-dihydroxyphenyl)-8-oxa-9λ⁵-phosphatricyclo[8.4.0.0²,⁷]tetradeca-1(14),2,4,6,10,12-hexaen-9-one
Test material form:
solid: particulate/powder

Results and discussion

Results: P0 (first parental generation)

Effect levels (P0)

Key result
Dose descriptor:
other: QSAR data not specified
Effect level:
0 mg/kg bw/day (nominal)
Based on:
not specified
Sex:
not specified
Basis for effect level:
other: QSAR - Both general fragments of DOPO-HQ are predicted negative by the TIMES ERBA +S9 model. The predictions are 100% in the model domain and correspond

Results: P1 (second parental generation)

Effect levels (P1)

Key result
Dose descriptor:
other: QSAR data not specifed
Effect level:
0 other: QSAR data not specified
Based on:
not specified
Sex:
not specified
Basis for effect level:
other: Both general fragments of DOPO-HQ (DOPO and HQ) are predicted negative by the TIMES ERBA +S9 model. The predictions are 100% in the model domain and correspond

Results: F1 generation

Effect levels (F1)

Key result
Dose descriptor:
other: QSAR analysisi data snot specified
Generation:
F1
Effect level:
0 other: QSAR data not specified
Based on:
not specified
Sex:
not specified
Basis for effect level:
other: Both general fragments of DOPO-HQ (DOPO and HQ) are predicted negative by the TIMES ERBA +S9 model. The predictions are 100% in the model domain and correspond

Overall reproductive toxicity

Key result
Reproductive effects observed:
not specified
Lowest effective dose / conc.:
15 mg/kg bw/day (nominal)
Treatment related:
not specified

Applicant's summary and conclusion

Conclusions:
Conclusions on reproductive toxicity:
 Both general fragments of DOPO-HQ (DOPO and HQ) are predicted negative by the TIMES ERBA +S9 model.
The predictions are 100% in the model domain and correspond to the experimental data available in TB. This ensure the reliability of the predictions.

 The target chemical is predicted negative based on RA prediction with the experimental ERBA data for DOPO and HQ.
Executive summary:

Endocrine disruptors are one group of substances that may be toxic to reproduction. Therefore the estrogen binding affinities (ERBA) of both general fragments of DOPO-HQ are examined. The ERBA assessments are performed by employing TIMES model and QSAR TBsoftware.

The TIMESEstrogen Binding Affinity S9 activatedmodel estimates thein vitrorelative binding affinity of chemicals to interact with the human/trout estrogen receptor. TIMESin vitroERBA model usesin vitrorat liver microsomal/S9 simulator to predict the metabolic activation of chemicals.

Both analyzed fragments (HQ and DOPO) are predicted asnegativeby the TIMES ERBA model. Both predictions are 100% in the model applicability domain.

Relative ERBA experimental data for HQ and DOPO are available in TB. They are used to predict the target chemical. The ERBA (Recombinant human estrogen receptor) of the DOPO-HQ is predicted to0%(i.e. Not active) (Figure 8 in the attached full repoport).

Additional NOEL/NOAEL data for HQ is available in TB(see Table 3 below). It was reported that the HQ did not produce dominant lethality as evidenced by examination of the reproductive indices following mating to untreated virgin females during the two weeks immediately following the final treatment.

Table 3. Experimental NOEL/NOAL data for toxicity to reproduction of HQ

 

HQ

 

Exp. data

Toolbox database

NOEL

100 mg/kg bdwt/d

ECHA CHEM

300 mg/kg bdwt/d

ECHA CHEM

NOAEL

15 mg/kg bdwt/d

ECHA CHEM

150 mg/kg bdwt/d

ECHA CHEM